Abstract:Background: White matter hyperintensities of presumed vascular origin (WMH) are the most prominent imaging feature of cerebral small vessel disease (cSVD). Previous studies suggest a link between cSVD burden and intracerebral hemorrhage and worse functional outcome after thrombolysis in acute ischemic stroke. We aimed to determine the impact of WMH burden on efficacy and safety of thrombolysis in the MRI-based randomized controlled WAKE-UP trial of intravenous alteplase in unknown onset stroke. Methods: The design of this post hoc study was an observational cohort design of a secondary analysis of a randomized trial. WMH volume was quantified on baseline fluid-attenuated inversion recovery images of patients randomized to either alteplase or placebo in the WAKE-UP trial. Excellent outcome was defined as score of 0-1 on the modified Rankin Scale after 90 days. Hemorrhagic transformation was assessed on follow-up imaging 24-36 hours after randomization. Treatment effect and safety were analyzed by fitting multivariable logistic regression models. Results: Quality of scans was sufficient in 441 of 503 randomized patients to delineate WMH. Median age was 68 years, 151 patients were female, and 222 patients were assigned to receive alteplase. Median WMH volume was 11.4 mL. Independent from treatment, WMH burden was statistically significantly associated with worse functional outcome (odds ratio, 0.72 [95% CI, 0.57-0.92]), but not with higher chances of any hemorrhagic transformation (odds ratio, 0.78 [95% CI, 0.60-1.01]). There was no interaction of WMH burden and treatment group for the likelihood of excellent outcome (P=0.443) or any hemorrhagic transformation (P=0.151). In a subgroup of 166 patients with severe WMH, intravenous thrombolysis was associated with higher odds of excellent outcome (odds ratio, 2.40 [95% CI, 1.19-4.84]) with no significant increase in the rate of hemorrhagic transformation (odds ratio, 1.96 [95% CI, 0.80-4.81]). Conclusions: Although WMH burden is associated with worse functional outcome, there is no association with treatment effect or safety of intravenous thrombolysis in patients with ischemic stroke of unknown onset. Registration: URL: https://www. Clinicaltrials: gov; Unique identifier: NCT01525290.

Cerebral computed tomography-graded white matter lesions are associated with worse outcome after thrombolysis in patients with stroke

Association Between Remote Diffusion-Weighted Imaging Lesions and Cerebral Small Vessel Disease in Primary Intracerebral Hemorrhage

White Matter Lesions Double the Risk of Post-Thrombolytic Intracerebral Hemorrhage

[Impact of Cerebral Microbleeds on Outcomes of Acute Ischemic Stroke Treated with Intravenous Thrombolysis].

Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.

Global White Matter Hypoperfusion on CT Predicts Larger Infarcts and Hemorrhagic Transformation after Acute Ischemia.

Extensive Cerebral Microbleeds Predict Parenchymal Haemorrhage and Poor Outcome after Intravenous Thrombolysis

Relationship Between White-Matter Hyperintensities and Hematoma Volume and Growth in Patients with Intracerebral Hemorrhage

Ipsilateral Prominent Thalamostriate Vein on Susceptibility-Weighted Imaging Predicts Poor Outcome after Intravenous Thrombolysis in Acute Ischemic Stroke.

Abstract W P43: Extent of “blooming Effect” Predicts Middle Cerebral Artery Recanalization after Intravenous Thrombolysis

Cerebral white matter lesions and post-thrombolytic remote parenchymal hemorrhage

The Relationship Between T2 White-Matter Hyperintensities and Hemorrhagic Transformation and Neurological Outcome after Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Intravenous Thrombolysis in Patients With White Matter Hyperintensities in the WAKE-UP Trial

Factors associated with symptomatic intracranial haemorrhage after intravenous thrombolysis in severe white matter lesions: a retrospective analysis

Abstract WP186: The Burden of White Matter Hyperintensities on Function Outcomes in Patients Treated for Acute Ischemic Stroke: A Post-Hoc Analysis of the IMS-III Trial

Susceptibility-diffusion mismatch predicts thrombolytic outcomes: a retrospective cohort study.

Significance of Cerebral Small-Vessel Disease in Acute Intracerebral Hemorrhage

Influence of White Matter Lesions on the Prognosis of Acute Cardioembolic Stroke Without Reperfusion Therapy

White Matter Lesions Predict Recurrent Vascular Events in Patients with Transient Ischemic Attacks.

White matter hyperintensities rather than the overall burden of cerebral small vessel disease is correlated with the outcomes in patients with acute ischemic stroke

Deep learning-based white matter lesion volume on CT is associated with outcome after acute ischemic stroke